Marc Tessier-Lavigne - 31 Dec 2021 Form 5 Insider Report for Denali Therapeutics Inc. (DNLI)

Role
Director
Signature
/s/ Tyler Nielsen, by power of attorney
Issuer symbol
DNLI
Transactions as of
31 Dec 2021
Net transactions value
$0
Form type
5
Filing time
17 Feb 2022, 19:25:24 UTC
Previous filing
30 Dec 2021
Next filing
05 Jan 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DNLI Common Stock Gift $0 -200,000 -8.9% $0.000000 2,044,370 13 Dec 2021 Direct F1, F2
holding DNLI Common Stock 78,848 31 Dec 2021 The Tessier-Lavigne/Hynes Irrevocable Trust 1 F3
holding DNLI Common Stock 79,173 31 Dec 2021 The Tessier-Lavigne/Hynes Irrevocable Trust 2 F4
holding DNLI Common Stock 78,848 31 Dec 2021 The Tessier-Lavigne/Hynes Irrevocable Trust 3 F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction involved a gift of securities by the Reporting Person. Disposition price is not applicable as this transaction was a bona fide gift.
F2 Includes 2,074 restricted stock units.
F3 The shares are held of record by The Tessier-Lavigne/Hynes Irrevocable Trust 1, for which the Reporting Person Serves as Trustee.
F4 The shares are held of record by The Tessier-Lavigne/Hynes Irrevocable Trust 2, for which the Reporting Person Serves as Trustee.
F5 The shares are held of record by The Tessier-Lavigne/Hynes Irrevocable Trust 3, for which the Reporting Person Serves as Trustee.